RTSN insider trading

Retension Pharmaceuticals, Inc.: insider trade history from SEC Form 4 filings.

Total Form 4 trades
12
Last 90 days
12
Buys / sells
17% / 0%
Market cap
—

RTSN insider activity at a glance

FilingIQ tracks 12 insider transactions for RTSN in filings since Oct 13, 2026. The most recent transaction is dated Oct 13, 2026.

Across the full history, 2 open-market purchases and 0 open-market sales were filed under transaction codes P and S respectively. Compensatory share awards (code A) and option exercises (code M) are tracked separately and not counted here.

The average FilingIQ composite score on RTSN insider trades is 56.0/100, produced by FilingIQ's multi-factor Form 4 model. Model framework documented at methodology.

Latest RTSN Form 4 filings

Most recent disclosures. Sign up to filter by score, transaction code, or insider role.

Frequently asked

How many insider trades does FilingIQ track for RTSN?
FilingIQ tracks 12 Form 4 insider transactions for RTSN (Retension Pharmaceuticals, Inc.), covering filings from Oct 13, 2026 onwards. 12 of those are dated within the last 90 days.
Are RTSN insiders net buyers or net sellers?
Across the full Form 4 history for RTSN, 2 transactions (17%) were open-market purchases and 0 (0%) were open-market sales. Compensatory awards and option exercises are filtered out of these counts.
Where does RTSN insider data come from?
Every transaction shown on this page is sourced directly from SEC EDGAR Form 4 filings. FilingIQ normalises insider identity across reporting variations and scores discretionary open-market purchases and sales on its multi-factor composite model.

Methodology & sources

Every RTSN insider transaction shown on FilingIQ is parsed directly from a public SEC Form 4 XML filing. Insider identity is normalised across reporting variants (CIK changes, name spellings, related-party indirect holdings). The FilingIQ composite score is documented in full on the team page and algo disclosure. Not investment advice; see disclaimer.